Palatin breaks off merger with MBI (Molecular Biosystems) at eleventh hour
This article was originally published in Clinica
Executive Summary
Palatin Technologies, an imaging agent company which had announced that it was going to buy Molecular Biosystems, makers of the Optison cardiac imaging agent, has pulled out of the $30 million deal announced last November, saying that it is no longer in the best interests of shareholders.